Citigroup
VTYX

Citigroup’s Ventyx Biosciences VTYX Stock Holding History

Citigroup’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-89,700
Closed -$2.94M – 5814
2023
Q2 		$2.94M Buy
89,700
+59,700
+199% +$2.06M ﹤0.01% 1874
2023
Q1 		$1M Buy
+30,000
New +$1.17M ﹤0.01% 2554

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's VTYX Position: Q1 2026 in Review

Citigroup sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 56,344 shares — an estimated $509K sold.

Citigroup first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $1.52M in Q2 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Citigroup reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 56,344 Ventyx Biosciences shares in Q1 2026, an estimated $509K.
  • Citigroup first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
  • Citigroup's Ventyx Biosciences position peaked at $1.52M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.